Key Events This Week
22 Jun: Stock declined 2.00% to Rs.677.35 amid bearish technical momentum
23 Jun: Intraday high of Rs.735 reached with a 4.98% daily gain
24 Jun: Minor dip of 0.06% to Rs.710.65 on low volume
25 Jun: Stock fell 2.69% to Rs.691.50, closing near week’s open

Aarti Pharmalabs Ltd Surges 7.53% to Day's High of Rs 735 — Outperforms Sector by 6.13 Percentage Points
2026-06-23 10:02:34The Sensex edged up 0.10% on 23 Jun 2026, while Aarti Pharmalabs Ltd surged 7.53% to touch an intraday high of Rs 735, outperforming its Pharmaceuticals & Biotechnology sector by 6.13 percentage points. This sharp single-session gain stands out as a significant stock-specific event amid a broadly positive but modest market advance.
Read full news article
Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-06-23 08:07:58Aarti Pharmalabs Ltd has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook as of mid-June 2026. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, reflecting both caution and pockets of bullishness amid broader market pressures.
Read full news article
Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-06-22 08:03:39Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a 5.01% gain on 22 Jun 2026, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-06-21 10:10:35Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article









